Location: San Francisco Bay Area
Member Since: 2013
Chief Operating Officer and Chief Development Officer
June Lee, M.D., is Chief Operating Officer of MyoKardia, a publicly traded biotechnology company focused on developing precision therapeutics for catdiomyopathies. Dr. Lee has significant experience leading early clinical development programs and is also a recognized leader in academic translational research. Dr. Lee is an adjunct professor at the University of California, San Francisco (UCSF) School of Medicine, where she formerly served as Director of Translational Research and Director of Catalyst Program which is an internal accelerator at UCSF for early stages technologies in therapeutics, devices, diagnostics, and digital health. A key focus of Dr. Lee’s work was identifying the most compelling discovery research and enabling and supporting its commercialization. Previously, she worked in early clinical development in cardiovascular, metabolism, respiratory, and infectious diseases at Genentech. Dr. Lee is a member of the Translational Research Advisory Council of the MOGAM Research Institute, and the MTRAC for Life Sciences Innovation Hub Therapeutic/Diagnostic Oversight Committee, a unit associated with The University of Michigan Medical School.
Dr. Lee completed her undergraduate work in chemistry at the Johns Hopkins University, earned her M.D. degree at the School of Medicine at University of California, Davis, and her clinical training in internal medicine and pulmonary/critical care and UCLA and UCSF.